ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Valve Disease

May 22, 2018
A 77-year-old woman underwent triple valve repair using three remodeling annuloplasty rings for moderate-to-severe insufficiency of her aortic, mitral, and tricuspid valves.
May 18, 2018
Patient Care Three-dimensional heart models help patients and families understand congenital heart defects at a hospital in Seattle, Washington, USA.
May 17, 2018
Roberto Lorusso of the Maastricht University Medical Center in the Netherlands discusses the Perceval valve and the ongoing PERSIST-AVR trial.
May 16, 2018
These videos review basic echocardiography and transesophageal echocardiography for surgeons.
April 27, 2018
In a recent issue of the European Journal of Cardio-Thoracic Surgery, Ammannaya and colleagues studied the relationship between prosthesis patient mismatch (PPM), pulmonary hypertension, and outcomes following mitral valve replacement to better understand the importance of avoiding PPM during this procedure.
April 26, 2018
The authors retrospectively evaluated the long-term fate of the aortic arch in 168 patients with bicuspid aortic valves who had undergone either ascending aortic (24%) or aortic root (76%) replacement.  At a median follow-up of 5.9 years, the mean aortic arch diameter went from 2.9 cm preoperatively to 3.0 cm at follow-up (p=ns).  The authors conclud
April 20, 2018
Filmed at the 2017 EACTS Annual Meeting, Octavio Alfieri, David Adams, Vinay Bapat, Michael Borger, and Randy Martin discuss the current state and future of treatment for mitral and tricuspid valve disease.
April 17, 2018
This video shows a right minithoracotomy for a complex mitral and tricuspid repair.
April 10, 2018
This is a retrospective review of 143 patients requiring reoperation after an initial AVR with a Freestyle® stentless bioprosthesis. Valve survival was 10.4 years for those with structural valve deterioration, but it was much less (4.1 years) if the initial procedure was for infective endocarditis. Operative mortality was <2%.

Pages